Search Results - "Zampetti, Benedetta"
-
1
Bilateral inferior petrosal sinus sampling
Published in Endocrine Connections (01-07-2016)“…Simultaneous bilateral inferior petrosal sinus sampling (BIPSS) plays a crucial role in the diagnostic work-up of Cushing’s syndrome. It is the most accurate…”
Get full text
Journal Article -
2
Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's Disease
Published in Endocrine, metabolic & immune disorders drug targets (01-01-2024)“…Pasireotide is a multireceptor somatostatin analogue approved for the treatment of patients with Cushing's disease (CD) who are ineligible or poor candidates…”
Get more information
Journal Article -
3
Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma
Published in Journal of Oncology (01-01-2012)“…Malignant pheochromocytomas/paragangliomas are rare tumors with a poor prognosis. Malignancy is diagnosed by the development of metastases as evidenced by…”
Get full text
Journal Article -
4
Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)
Published in Medicina (Kaunas, Lithuania) (13-06-2022)“…Somatostatin receptor ligands (SRLs) represent a true milestone in the medical therapy for acromegaly. The first-generation SRLs (FG-SRLs), octreotide and…”
Get full text
Journal Article -
5
Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study
Published in Frontiers in endocrinology (Lausanne) (01-02-2024)“…Acromegaly is caused by excessive growth hormone (GH) and insulin-like growth factor 1 (IGF1). Medical therapy plays a role as a treatment option for…”
Get full text
Journal Article -
6
A Tale of Two Hypersecreting Adrenal Neoplasms in the Heartland of COVID-19 Pandemic, Lombardy, Italy
Published in Case reports in endocrinology (18-02-2022)“…In this study, we report the management, in Lombardy, Italy, of one patient with Cushing’s syndrome due to adrenal adenoma and another one with…”
Get full text
Journal Article -
7
Osilodrostat in Cushing’s disease: the management of its efficacy and the pitfalls of post-surgical results
Published in Endocrinology, diabetes & metabolism case reports (01-11-2022)“…Summary Osilodrostat is a novel, orally administered cortisol synthesis inhibitor, approved in 2020 by the European Medicines Agency (EMA) for the treatment of…”
Get full text
Journal Article -
8
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients
Published in Endocrine-related cancer (01-04-2012)“…Head and neck paragangliomas (HNPGLs) are neural crest-derived tumors. In comparison with paragangliomas located in the abdomen and the chest, which are…”
Get full text
Journal Article -
9
ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow
Published in Biomedicines (01-03-2023)“…Secondary Adrenal Insufficiency (SAI) is a condition characterized by inappropriately low ACTH secretion due to a disease or injury to the hypothalamus or the…”
Get full text
Journal Article -
10
Hyponatremia after anticoagulant treatment: a rare cause of adrenal failure
Published in Endocrinology, diabetes & metabolism case reports (24-09-2018)“…Summary A 69-year-old male was admitted for severe hyponatremia disclosed after an accidental fall. He was anticoagulated from 2 months after the implantation…”
Get full text
Journal Article -
11
Effective long-term temozolomide rechallenge in a macroprolactinoma
Published in Endocrinology, diabetes & metabolism case reports (01-10-2018)“…Summary We describe the 20-year course of a 63-year-old male with a macroprolactinoma that acquired resistance to treatment and aggressive behavior after a…”
Get full text
Journal Article -
12
Six controversial issues on subclinical Cushing’s syndrome
Published in Endocrine (01-05-2017)“…Subclinical Cushing’s syndrome is a condition of hypercortisolism in the absence of signs specific of overt cortisol excess, and it is associated with an…”
Get full text
Journal Article -
13
False Positive of 68 Ga-DOTATATE PET-CT in a Paraganglioma
Published in Endocrine, metabolic & immune disorders drug targets (2021)“…Functional imaging with Ga-DOTATATE PET-CT is widely employed to detect both primary and metastatic pheochromocytomas and paragangliomas (PGL), but its results…”
Get more information
Journal Article -
14
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas—Case Report
Published in The journal of clinical endocrinology and metabolism (01-07-2014)“…Context: About 35% of patients with pheochromocytoma/paraganglioma carry a germline mutation in one of the 10 main susceptibility genes. The recent…”
Get full text
Journal Article -
15
Metyrapone Treatment in Endogenous Cushing’s Syndrome: Results at Week 12 From PROMPT, a Prospective International Multicenter, Open-Label, Phase III/IV Study
Published in Journal of the Endocrine Society (03-05-2021)“…Abstract Background: Metyrapone is a steroidogenesis inhibitor approved in Europe for the treatment of endogenous Cushing’s syndrome (CS) based on…”
Get full text
Journal Article -
16
Effectiveness of low‐dose pasireotide in a patient with Cushing's disease: antiproliferative effect and predictivity of a short pasireotide suppression test
Published in Clinical case reports (01-08-2015)“…Key Clinical Message This case shows efficacy of low‐dose pasireotide in biochemical and clinical control of severe hypercortisolism and in tumor volume…”
Get full text
Journal Article -
17
-
18
Succinate Dehydrogenase Subunit B Mutations Modify Human Neuroblastoma Cell Metabolism and Proliferation
Published in Hormones & cancer (01-06-2014)“…Paragangliomas (PGLs) are rare neuroendocrine tumours. About 30–40 % of these tumours are mutated in one of the different susceptibility genes, including those…”
Get full text
Journal Article -
19